So-Young International Inc. Files Its Annual Report on Form 20-F
BEIJING, China, April 27, 2020 (GLOBE NEWSWIRE) — So-Young International Inc. (Nasdaq: SY) (“So-Young” or the “Company”), the largest and […]
DASAN Zhone Solutions Sets First Quarter 2020 Earnings Call for Thursday, May 7, 2020 at 5:00 p.m. ET
ALAMEDA, Calif., April 27, 2020 (GLOBE NEWSWIRE) — DASAN Zhone Solutions, Inc. (NASDAQ: DZSI or the “Company” or “DZS”), a […]
AMG Reports Financial and Operating Results for the First Quarter of 2020
Continue to address the impact of the COVID-19 pandemic on AMG’s Affiliates, business, employees, and surrounding communities — including supporting […]
Six COVID-19 Patients Treated with RedHill’s Opaganib Under Compassionate Use Show Objective Clinical Improvement
Preliminary data in moderate-to-severe COVID-19 patients treated with opaganib show measurable clinical improvement in all six patients analyzed, including decreased […]
Medigus Signs a Collaboration Agreement with L1 Systems for the Commercialization of COVID-19 Medical Products and Solutions
OMER, Israel, April 27, 2020 (GLOBE NEWSWIRE) — Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a technology company developing minimally invasive tools and […]
Kamada and Kedrion Biopharma Announce Global Collaboration for the Development, Manufacturing and Distribution of a Plasma-Derived Anti-SARS-CoV-2 (COVID-19) Polyclonal Immunoglobulin Product
Kamada is Responsible for Product Development, Manufacturing, Clinical Development, and Regulatory Submissions, as well as Distribution in Territories not under […]
B COMMUNICATIONS LTD. RECEIVES NASDAQ LETTER REGARDING NON-COMPLIANCE WITH MINIMUM BID PRICE REQUIREMENT
Tel Aviv, Israel, April 27, 2020 (GLOBE NEWSWIRE) — B Communications Ltd. (NASDAQ and TASE: BCOM) (“BCOM” or the “Company”) […]
Arcturus Reports Positive Preclinical Data for its COVID-19 Vaccine Candidate
100% of animals seroconverted by day 19 at a low dose (2 µg)LUNAR-COV19 remains on track to initiate human clinical […]
LEXICON PHARMACEUTICALS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE
THE WOODLANDS, Texas, April 27, 2020 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results and provided […]
Avadel Pharmaceuticals Announces Positive Topline Results from its Pivotal Phase 3 REST-ON Trial of Once-Nightly FT218 for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Patients with Narcolepsy
The primary analysis of investigational, once-nightly FT218 at 9 g demonstrated highly statistically significant (p<0.001), and clinically meaningful improvement across […]
